Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.
about
The role of natriuretic peptides for the diagnosis of left ventricular dysfunctionEarly management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working groupThe clinical features of takotsubo cardiomyopathyEffects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitorsB-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.Is B-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? Data from the Heart and Soul Study.B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic studyCharacteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide.N-terminal pro-B-type natriuretic Peptide in overweight and obese patients with and without diabetes: an analysis based on body mass index and left ventricular geometry.Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney DiseasePlasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort studyRapid detection of natriuretic peptides by a microfluidic LabChip analyzer with DNA aptamers: Application of natriuretic peptide detection.Early change of extracellular matrix and diastolic parameters in metabolic syndrome.B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, ArgentinaMeasurement of the renin-angiotensin system in heart failure.B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide.Relationship of left atrial global peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in patients presenting with non-ST elevation myocardial infarction.Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trialsA pig model of ischemic mitral regurgitation induced by mitral chordae tendinae rupture and implantation of an ameroid constrictorPulmonary transfusion reactions.The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting.Genetic variation in the natriuretic peptide system and heart failure.Nesiritide: a novel approach for acute heart failure.Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group.Plasma Brain Natriuretic Peptide (BNP) as an Indicator of Left Ventricular Function, Early Outcome and Mechanical Complications after Acute Myocardial Infarction.Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management.Relationship between serum N-terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) level and the severity of coronary artery involvements.Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients.Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome.Normal values of B type natriuretic peptide in infants, children, and adolescents.Preload-based starling-like control for rotary blood pumps: numerical comparison with pulsatility control and constant speed operation.Serum troponins as biomarkers of drug-induced cardiac toxicity.BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.Candidate-based proteomics in the search for biomarkers of cardiovascular disease.Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions.Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology groupN-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation.The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure.
P2860
Q26825665-728E5CD0-88C8-4714-86A8-3C132B51858AQ27000455-1B22F58B-0975-4797-8CFB-D611EC17D890Q28191673-6B64D07B-C152-440E-AEED-513CCF4462BAQ28200166-82A8950A-806B-4DF6-91D2-E58676E179A7Q30885744-73C8FC52-F322-4BD4-B40C-8799251E4899Q30919400-208D8253-3237-45C9-894F-D5C2AE3061EDQ33387034-7891C789-8EDC-4A1A-8951-7BC0F17D4D5DQ33402666-96E68BFB-74A4-43D6-AF71-A6BAEBAD9B28Q33570560-FDB1DC5A-5DFC-4575-9061-75CAC0B38D1EQ33698495-05F62BA5-5E93-4AF7-97DC-F0D303BDDCA2Q33699467-FE27A352-CC55-400F-B0DA-83074763BF09Q33714038-0CCADF9A-806A-4219-A93F-B8C3E6F7B082Q33773332-EDF019C5-F4A1-429B-9D4A-6993E9A541E0Q34035094-755F8316-C69F-4D34-8799-B2E07EBA4D5DQ34170513-CD0F209F-DC07-46DB-84F4-BDD41D6CD8D0Q34297057-5B642185-3943-4E4D-B670-FAB75613EB9DQ34304189-D9885F3C-2A3C-4156-B735-6E469B905D92Q34428306-7C27277F-C5EE-4B11-8931-9FC16677A038Q34614873-593F3BA0-540B-40CB-ACA6-17414D1A5738Q34639417-72D7F044-D2D5-4AE6-A2FA-B25B5B2DE859Q34790939-BF9B4900-83AE-4896-87A6-C64E16447C3AQ34796770-D3671E30-8CD9-4D70-B6EF-805977668D62Q35046791-FE4589A6-22B1-4143-B1B2-266FA2518EECQ35054263-4ECF45E3-1B7D-4A99-8F72-D03579B254A7Q35057622-D1527E01-AB75-482A-91FC-CB9256293FBFQ35193187-997944DC-D964-4A1C-B9DE-E26DD679BB9BQ35200873-2952E438-3461-4429-BF9B-4A08E165A117Q35544633-CA4253A3-EBA0-47B1-A88C-61F5B193E327Q35554770-AA857ACC-200D-4030-974D-37DF91D1BC58Q35560785-60D895DC-1617-4E21-902A-278443FBF58CQ35581437-241F55F4-9D14-4989-ACCC-28FC29E16846Q35596834-902A89A8-4A43-405E-B2C0-2F71ABC7EAC9Q35624619-D0607215-ED91-48E2-9DBB-910B703FCCE9Q35987052-2625AB40-7864-495D-B494-06E7C176FB1FQ35990040-F73FCBA7-45E6-4E8B-A4C6-1BEDFC14E500Q36015470-2566C7E6-632F-42E7-8E32-21AC28745B42Q36097717-3A59EEEF-A54A-4FAE-90E7-039061623D0AQ36124913-ADB2A277-255B-4D97-8500-C8BE5BE9A8ACQ36146288-875EB6D2-751F-48E5-A57E-D0617DE033E7Q36352015-2AEBDF7D-A7F7-41CA-8727-42A2091C83D5
P2860
Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Plasma brain natriuretic pepti ...... left ventricular dysfunction.
@en
Plasma brain natriuretic pepti ...... left ventricular dysfunction.
@nl
type
label
Plasma brain natriuretic pepti ...... left ventricular dysfunction.
@en
Plasma brain natriuretic pepti ...... left ventricular dysfunction.
@nl
prefLabel
Plasma brain natriuretic pepti ...... left ventricular dysfunction.
@en
Plasma brain natriuretic pepti ...... left ventricular dysfunction.
@nl
P2093
P1476
Plasma brain natriuretic pepti ...... left ventricular dysfunction.
@en
P2093
P304
P356
10.1016/S0002-8703(98)70041-9
P407
P433
P577
1998-05-01T00:00:00Z